Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-27

Clinical Trial Update: Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating aspirin and rintatolimod with or without interferon-alpha 2b in patients with prostate cancer undergoing surgery; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Interferon-alpha-2b (interferon alfa-2b)
  • Rintatolimod (rintatolimod)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING